retatrutide liver disease Fatty was alleviated by Lilly's 'triple-G' obesity drug Advances in the Management of

L., & Redinbo, M

doi: 10.1016/j.mce.2022.111645 149 SmyrniasIZhangXZhangMMurrayTVBrandesRPSchrderKet al

Peng et al., 2001

It is the pharmacological equivalent of pointing a targeted spotlight at liver fat specifically and saying "burn this." For anyone concerned about metabolic health beyond simple weight management, this liver fat data may be the single most important differentiator between the two compounds

I recently learned about retatrutide through an acquaintance a recreational weightlifter whos been selfadministering this investigational triple G peptide (mimicking GLP1, GIP, and glucagon)

The medication can reduce thirst signals, yet dehydration intensifies nausea and appetite dysregulation